Halozyme Therapeutics, Inc.HALONASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank100
3Y CAGR+76.0%
5Y CAGR+50.0%
Studio
Year-over-Year Change

Return on equity

3Y CAGR
+76.0%/yr
Annual compound
5Y CAGR
+50.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
7.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025649.18%+431.8%
2024122.06%-63.7%
2023336.00%+182.3%
2022119.04%-41.8%
2021204.47%+139.3%
202085.46%+208.6%
2019-78.72%-143.9%
2018-32.28%-206.8%
201730.22%-90.5%
2016317.18%-